Siemens Medical Solutions plans to begin marketing by year-end a hardware-software combination that supports arterial spin labeling, a noncontrast-based imaging technique, as part of an integrated package for the assessment of ischemic stroke.
Siemens Medical Solutions plans to begin marketing by year-end a hardware-software combination that supports arterial spin labeling, a noncontrast-based imaging technique, as part of an integrated package for the assessment of ischemic stroke.
The technology, currently in development, will allow a comprehensive evaluation of ischemic disease, according to Jeffrey M. Bundy, Ph.D., senior director of MR R&D for Siemens. It will correlate structural and functional data and diffusion and perfusion data obtained not only through arterial spin labeling but through methods including blood oxygen level-dependent contrast.
"It's not a stand-alone technique, but it will be integrated into other tools that we already have as a product," Bundy said.
Siemens will acquire these data using 3T, improved radiofrequency, and a 12-channel head coil. A 32-channel coil is in development. The company also plans to offer a 1.5T version, which will use similar technologies, including a 12-channel head coil.
"To do this, you need all the pieces," he said.
Arterial spin labeling visualizes blood flow without enhancement by contrast agents. The ability to do so depends on having enough signal to noise to distinguish changes in tissue magnetization resulting from blood versus tissue water. The increased signal-to-noise ratio allows for a more precise visualization of the affected brain area than can be achieved with conventional methods, according to Ionnis Panagiotelis, Ph.D., market manager for the ultra high-field segment at Siemens.
Siemens is releasing the brain assessment package with arterial spin labeling initially to luminaries in academia and clinical practice who have served previously as research collaborators. The goal will be to gain experience with the technology and validate its clinical utility. A broader commercial release is expected by the end of the calendar year.
"Providing it within our standard neuro tools will allow customers to integrate arterial spin labeling very quickly and easily in their daily workflow," Bundy said.
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.